Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC) Meeting Abstract
| Authors: | Dunn, L.; Riaz, N.; Baxi, S. S.; McBride, S. M.; Sherman, E. J.; Michel, L.; Haque, S.; Katabi, N.; Wong, R. J.; Xiao, H.; Lee, N. Y.; Fury, M. G.; Ho, A. L.; Pfister, D. G. |
| Abstract Title: | Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 335s |
| Language: | English |
| ACCESSION: | WOS:000411931705077 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.6081 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6081 -- Source: Wos |
